Takeda: Dengue Vaccine Candidate Works Without Big Safety Risks ...Middle East

Takeda's TAK-003 dengue vaccine showed long-term efficacy and no antibody-dependent enhancement reactions in seronegative patients. It can be given without prior serologic testing. Medscape Medical News

Hence then, the article about takeda dengue vaccine candidate works without big safety risks was published today ( Friday 10/06/2022 - 03:28 AM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Takeda: Dengue Vaccine Candidate Works Without Big Safety Risks )

Also on site :

• 13-year-old rider dies following incident at northwest Indiana BMX park
• The 68th Annual Grammy Awards Red Carpet 2026: See the Fabulous Fashions Worn by Your Favorite Music Makers
• Ukrainian drone strike kills woman and child near Mariupol – authorities